↓ Skip to main content

Decision Support Tool Identifies Ulcerative Colitis Patients Most Likely to Achieve Remission With Vedolizumab vs Adalimumab

Overview of attention for article published in Inflammatory Bowel Diseases, December 2021
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
25 Mendeley
Title
Decision Support Tool Identifies Ulcerative Colitis Patients Most Likely to Achieve Remission With Vedolizumab vs Adalimumab
Published in
Inflammatory Bowel Diseases, December 2021
DOI 10.1093/ibd/izab310
Pubmed ID
Authors

Parambir S Dulai, Emily C L Wong, Walter Reinisch, Jean-Frederic Colombel, John K Marshall, Neeraj Narula

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 8 32%
Researcher 3 12%
Student > Ph. D. Student 2 8%
Student > Master 2 8%
Student > Doctoral Student 1 4%
Other 4 16%
Unknown 5 20%
Readers by discipline Count As %
Unspecified 8 32%
Medicine and Dentistry 6 24%
Pharmacology, Toxicology and Pharmaceutical Science 2 8%
Biochemistry, Genetics and Molecular Biology 1 4%
Agricultural and Biological Sciences 1 4%
Other 3 12%
Unknown 4 16%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 January 2022.
All research outputs
#7,171,071
of 22,875,477 outputs
Outputs from Inflammatory Bowel Diseases
#1,474
of 3,470 outputs
Outputs of similar age
#159,950
of 500,024 outputs
Outputs of similar age from Inflammatory Bowel Diseases
#32
of 67 outputs
Altmetric has tracked 22,875,477 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 3,470 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 500,024 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 67 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.